210 related articles for article (PubMed ID: 17496556)
1. Competing events influence estimated survival probability: when is Kaplan-Meier analysis appropriate?
Biau DJ; Latouche A; Porcher R
Clin Orthop Relat Res; 2007 Sep; 462():229-33. PubMed ID: 17496556
[TBL] [Abstract][Full Text] [Related]
2. [Is Kaplan-Meier statistics the most appropriate tool for survivorship measurement of outcomes in orthopaedics?].
Langová K; Gallo J
Acta Chir Orthop Traumatol Cech; 2010 Apr; 77(2):118-23. PubMed ID: 20447354
[TBL] [Abstract][Full Text] [Related]
3. Actual and actuarial probabilities of competing risks: apples and lemons.
Grunkemeier GL; Jin R; Eijkemans MJ; Takkenberg JJ
Ann Thorac Surg; 2007 May; 83(5):1586-92. PubMed ID: 17462363
[TBL] [Abstract][Full Text] [Related]
4. Kaplan-Meier Survival Analysis Overestimates the Risk of Revision Arthroplasty: A Meta-analysis.
Lacny S; Wilson T; Clement F; Roberts DJ; Faris PD; Ghali WA; Marshall DA
Clin Orthop Relat Res; 2015 Nov; 473(11):3431-42. PubMed ID: 25804881
[TBL] [Abstract][Full Text] [Related]
5. [Long-term experience with the combined ARBOND hydroxyapatite coating in implant osteointegration].
Landor I; Vavrík P; Jahoda D; Pokorný D; Ballay R; Sosna A
Acta Chir Orthop Traumatol Cech; 2009 Jun; 76(3):172-8. PubMed ID: 19595277
[TBL] [Abstract][Full Text] [Related]
6. Survival analysis in total joint replacement: an alternative method of accounting for the presence of competing risk.
Fennema P; Lubsen J
J Bone Joint Surg Br; 2010 May; 92(5):701-6. PubMed ID: 20436009
[TBL] [Abstract][Full Text] [Related]
7. Cumulative incidence in competing risks data and competing risks regression analysis.
Kim HT
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):559-65. PubMed ID: 17255278
[TBL] [Abstract][Full Text] [Related]
8. Time-related analysis of nonfatal heart valve complications: cumulative incidence (actual) versus Kaplan-Meier (actuarial).
Grunkemeier GL; Anderson RP; Miller DC; Starr A
Circulation; 1997 Nov; 96(9 Suppl):II-70-4; discussion II-74-5. PubMed ID: 9386078
[TBL] [Abstract][Full Text] [Related]
9. Kaplan-Meier methods yielded misleading results in competing risk scenarios.
Southern DA; Faris PD; Brant R; Galbraith PD; Norris CM; Knudtson ML; Ghali WA;
J Clin Epidemiol; 2006 Oct; 59(10):1110-4. PubMed ID: 16980152
[TBL] [Abstract][Full Text] [Related]
10. Peritonitis-free survival in peritoneal dialysis: an update taking competing risks into account.
Evans DW; Ryckelynck JP; Fabre E; Verger C
Nephrol Dial Transplant; 2010 Jul; 25(7):2315-22. PubMed ID: 20103502
[TBL] [Abstract][Full Text] [Related]
11. Interpretation of nonfatal events after cardiac surgery: actual versus actuarial reporting.
Grunkemeier GL; Wu Y
J Thorac Cardiovasc Surg; 2001 Aug; 122(2):216-9. PubMed ID: 11479492
[TBL] [Abstract][Full Text] [Related]
12. Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications.
Varadhan R; Weiss CO; Segal JB; Wu AW; Scharfstein D; Boyd C
Med Care; 2010 Jun; 48(6 Suppl):S96-105. PubMed ID: 20473207
[TBL] [Abstract][Full Text] [Related]
13. Competing Risk of Death When Comparing Tibial Implant Types in Total Knee Arthroplasty.
Maradit Kremers H; Kremers WK; Sierra RJ; Lewallen DG; Berry DJ
J Bone Joint Surg Am; 2016 Apr; 98(7):591-6. PubMed ID: 27053588
[TBL] [Abstract][Full Text] [Related]
14. The analysis of competing events like cause-specific mortality--beware of the Kaplan-Meier method.
Verduijn M; Grootendorst DC; Dekker FW; Jager KJ; le Cessie S
Nephrol Dial Transplant; 2011 Jan; 26(1):56-61. PubMed ID: 21059831
[TBL] [Abstract][Full Text] [Related]
15. On the importance of accounting for competing risks in pediatric cancer trials designed to delay or avoid radiotherapy: I. Basic concepts and first analyses.
Tai BC; Grundy RG; Machin D
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1493-9. PubMed ID: 19577860
[TBL] [Abstract][Full Text] [Related]
16. [Medin modular implant for total knee arthroplasty--mid-term results].
Vavrík P; Landor I; Tomaides J; Popelka S
Acta Chir Orthop Traumatol Cech; 2009 Feb; 76(1):30-4. PubMed ID: 19268046
[TBL] [Abstract][Full Text] [Related]
17. Reoperative lower extremity revascularization with cadaver vein for limb salvage.
Bannazadeh M; Sarac TP; Bena J; Srivastava S; Ouriel K; Clair D
Ann Vasc Surg; 2009; 23(1):24-31. PubMed ID: 18657383
[TBL] [Abstract][Full Text] [Related]
18. Inferior outcome after intraoperative femoral fracture in total hip arthroplasty: outcome in 519 patients from the Danish Hip Arthroplasty Registry.
Thillemann TM; Pedersen AB; Johnsen SP; Søballe K
Acta Orthop; 2008 Jun; 79(3):327-34. PubMed ID: 18622835
[TBL] [Abstract][Full Text] [Related]
19. Endoprosthetic proximal femur replacement: metastatic versus primary tumors.
Potter BK; Chow VE; Adams SC; Letson GD; Temple HT
Surg Oncol; 2009 Dec; 18(4):343-9. PubMed ID: 18835153
[TBL] [Abstract][Full Text] [Related]
20. The effect of erythrocyte blood transfusions on survival after surgery for hip fracture.
Engoren M; Mitchell E; Perring P; Sferra J
J Trauma; 2008 Dec; 65(6):1411-5. PubMed ID: 19077635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
